Aug. 4 at 10:56 AM
$MD Q2 '26 Earnings Results & Recap
• Reported GAAP EPS of
$0.49 up 6.52% YoY
• Reported revenue of
$487.78M up 4.04% YoY
• Pediatrix Medical Group reaffirms its full year 2026 outlook for Adjusted EBITDA, as defined, and anticipates that Pediatrix Medical Group will report Adjusted EBITDA in a range of
$280 million to
$300 million.
